EPRX.TOライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (27 4月 2024 @ 05:00):

Eupraxia Pharmaceuticals Inc., a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector...

Stats
本日の出来高	15 050.00
平均出来高	68 096.00
時価総額	132.87M
EPS	$0 ( 2024-04-03 )
次の収益日	( $-0.340 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-3.19
ATR14	$0.0180 (0.48%)

Eupraxia Pharmaceuticals 相関

10 最も正の相関
TCL-A.TO	0.937
CFP.TO	0.902
AQN.TO	0.902
AW-UN.TO	0.901
BLX.TO	0.894
TULB.TO	0.893
WTE.TO	0.893
ESGF.TO	0.89
NPI.TO	0.89
BIP-UN.TO	0.889

10 最も負の相関
SUSA.TO	-0.93
IAF-PI.TO	-0.883
OBE.TO	-0.88
MEG.TO	-0.875
PEY.TO	-0.87
CTZ.V	-0.869
PKI.TO	-0.861
RQK.TO	-0.85
URB.TO	-0.843
VLE.TO	-0.842

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Eupraxia Pharmaceuticals 財務諸表

Annual	2023
収益:	$0
総利益:	$-209 911 (0.00 %)
EPS:	$-1.580

FY	2023
収益:	$0
総利益:	$-209 911 (0.00 %)
EPS:	$-1.580

FY	2022
収益:	$0
総利益:	$-193 273 (0.00 %)
EPS:	$-1.210

Financial Reports:

No articles found.

Eupraxia Pharmaceuticals

Eupraxia Pharmaceuticals Inc., a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector. The company's lead product candidate is EP-104IAR, which is in a Phase II clinical trial for the treatment of unmet medical needs and for pain relief for knee osteoarthritis, as well as under development for treating canine and equine osteoarthritis. Its products in development also include EP-201, an antibiotic for post-surgical site infections; and EP-105, an extended-release post-surgical anesthetic for post-surgical pain. In addition, the company develops product candidates for oncology. The company was formerly known as Plaza Capital Partners Inc. and changed its name to Eupraxia Pharmaceuticals Inc. in May 2012.Eupraxia Pharmaceuticals Inc. was incorporated in 2011 and is headquartered in Victoria, Canada.